This week, we respond to a recent Wall Street Journal article documenting immunotherapy as a new treatment for Cancer. We tell you what companies they missed.
OneMedRadio brings you management interviews with Synthetic Biologics, Pluristem, Nanoviricides, and Biovest.
We also interviewed Gerry DiFiore, partner at Reed Smith, sponsor of our recent OneMedForum NY 2012 kick off reception in New York City.
Gearing up for our third annual trans-Atlantic conference in New York, we have many new interesting companies slated to present. Stay tuned for feature articles highlighting these disruptive technologies. And don't forget to register to be present July 12th at OneMedForum New York.
Sincerely,
Brett Johnson
Related Posts
-
SalivaClear is to Help People Across the Nation Return to School and Work with a Self-Collection Approach that is Noninvasive and Simple.
-
Danish Study of 4,860 Finds .03 Divergence in Mask vis No Mask
-
The Fluxergy Approach Makes Testing Portable and Consolidates All of the Various Processes into One Device